What is the global market size of Vascular Closure Device Market?

Global Vascular Closure Device Market size was valued at USD 1.5 billion in 2021 and is poised to grow from USD 1.59 billion in 2022 to USD 2.64 billion by 2030, growing at a CAGR of 6.50% in the forecast period (2023-2030).

Global Vascular Closure Device Market Size, Share, Growth Analysis, By Product Type(Active Approximators and Passive Approximators), By Access(Femoral Access and Radial Access) - Industry Forecast 2024-2031

Report ID: SQMIG35A2810 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 59 | Figures: 75

Global Vascular Closure Device Market News

In March 2024, Haemonetics HAE entered into a definitive agreement to acquire privately held Attune Medical — the manufacturer of the ensoETM proactive esophageal cooling device. Attune Medical's ensoETM will bolster Haemonetics' presence in the electrophysiology market and complement its leadership in Vascular Closure.
In January 2024, University Hospitals (UH) Harrington Heart & Vascular Institute recently became the first center in the world to implant Medtronic’s Penditure Left Atrial Appendage (LAA) Exclusion System through a minimally invasive approach during a mitral valve repair procedure. This was also the first time this device and approach were used simultaneously in a human.
In August 2023, Haemonetics announced the first patients treated with its Vascade MVP venous vascular closure system in Germany.

Global Vascular Closure Device Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Vascular Closure Device Market size was valued at USD 1.59 billion in 2022 and is poised to grow from USD 1.69 billion in 2023 to USD 2.80 billion by 2031, growing at a CAGR of 6.50% in the forecast period (2024-2031).

The market exhibitions a moderate level of merging, with a handful of major players imposing a significant share of the revenue. These key industry participants are advantageously intent on the introduction of innovative products to support their market positioning. Additionally, their focus extends to performing strategic initiatives, including partnerships, product launches, and collaborations, enhancing their overall market presence. 'Abbott Laboratories', 'Terumo Corporation', 'Cardinal Health', 'Medtronic plc', 'Boston Scientific Corporation', 'Merit Medical Systems, Inc.', 'B. Braun Melsungen AG', 'Cook Medical', 'InSeal Medical', 'Marine Polymer Technologies, Inc.', 'Cardiva Medical, Inc.', 'Essential Medical, Inc.', 'Teleflex Incorporated', 'Vascular Solutions (Acquired by Teleflex)', 'Vivasure Medical Ltd.', 'Scion BioMedical', 'Transluminal Technologies', 'Morris Innovative, Inc.', 'TZ Medical, Inc.', 'Carden Jennings Publishing Co., Ltd.'

Cardiovascular diseases (CVDs) stand as a prominent global cause of mortality, contributing significantly to the overall death toll. According to data from the American Heart Association (AHA), CVDs accounted for 18.6 million deaths in 2019, with a notable concentration in Eastern Europe and Central Asia. The AHA further forecasts that by 2030, approximately 40.5% of the United States population is expected to experience some form of CVD. This escalating prevalence of cardiovascular diseases is poised to drive the demand for catheterization and interventional procedures aimed at diagnosing and treating CVDs. The growing popularity of these procedures is anticipated to be a key driver propelling the market for vascular closure devices in the forthcoming years.

A remarkable trend in the Vascular Closure Device market is the increasing importance of biodegradable closure devices. These innovative devices represent a significant leap in vascular interference technology by incorporating biodegradable materials that undergo progressive disintegration, promoting natural healing processes. Biodegradable closure devices offer distinct advantages, such as reducing the long-term presence of foreign materials within the body, mitigating potential complications associated with permanent implants. Their biocompatible nature aligns with the growing emphasis on patient safety and comfort. The demand for biodegradable closure devices is on the rise, driven by their ability to provide effective vascular closure while addressing concerns related to long-term implantation, making them a promising avenue for enhancing patient outcomes in minimally invasive vascular procedures.

In the year 2022, North America held a significant share in the vascular closure device market, recording revenues surpassing USD 689 million. The region is poised for sustained growth until 2032, primarily driven by the heightened prevalence of cardiovascular diseases. The expanding population of elderly individuals, who exhibit a greater susceptibility to cardiovascular ailments, has prompted the establishment of advanced healthcare infrastructure in the region. Furthermore, the presence of extensive reimbursement coverage for medical procedures acts as a compelling incentive for both healthcare professionals and patients. This, in turn, encourages the adoption of innovative treatment alternatives and contributes substantially to the overall progress and advancement of the market.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Vascular Closure Device Market Size, Share, Growth Analysis, By Product Type(Active Approximators and Passive Approximators), By Access(Femoral Access and Radial Access) - Industry Forecast 2024-2031

Global Vascular Closure Device Market News

Global Vascular Closure Device Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Vascular Closure Device Market?

Who are the key vendors in the Global Vascular Closure Device Market?

What is the key driver of Global Vascular Closure Device Market?

What is the key market trend for Global Vascular Closure Device Market?

Which region accounted for the largest share in Global Vascular Closure Device Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300